Lack of association of IL-6 polymorphism with rheumatoid arthritis/type 1 diabetes: A meta-analysis

被引:10
|
作者
Xu, Wang-Dong [1 ]
Zhou, Mo [1 ]
Peng, Hui [1 ]
Pan, Hai-Feng [1 ]
Ye, Dong-Qing [1 ]
机构
[1] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei 230032, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
IL-6; Polymorphism; Rheumatoid arthritis; Type; 1; diabetes; Meta analysis; SYSTEMIC-LUPUS-ERYTHEMATOSUS; APPARENTLY HEALTHY-MEN; ENDOTHELIAL DYSFUNCTION; PROMOTER POLYMORPHISM; AUTOIMMUNE-DISEASES; GENE POLYMORPHISMS; RISK-FACTORS; INTERLEUKIN-6; SUSCEPTIBILITY; MELLITUS;
D O I
10.1016/j.jbspin.2012.11.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this study was to determine whether the interleukin (IL)-6 -174 single nucleotide polymorphism confers susceptibility to rheumatoid arthritis (RA) and type 1 diabetes (T1D) in multiple ethnic populations. Methods: A meta-analysis was conducted on the association between the IL-6 -174 polymorphism and RA/T1D susceptibility, using fixed and random effects models. Results: Thirteen studies were included in the meta-analysis: RA: seven studies, including six European and one Asian population; T1D: six studies, including five European and one South American population. There was no significant association both in allele and genotype comparisons between the IL-6 -174 polymorphism and RA/T1D in all study subjects. Moreover, meta-analysis stratified by ethnicity indicated no significant association between the gene and RA/T1D. Conclusions: This meta-analysis suggests that the IL-6 -174 polymorphism might not confer susceptibility to RA/T1D. (C) 2013 Published by Elsevier Masson SAS on behalf of the Societe Francaise de Rhumatologie.
引用
收藏
页码:477 / 481
页数:5
相关论文
共 50 条
  • [31] Pathogenic roles of IL-6 and IL-6 blocking therapy on rheumatoid arthritis
    K Yoshizaki
    N Nishimoto
    N Miyasaka
    K Yamamoto
    S Kawai
    T Takeuchi
    T Kishimoto
    [J]. Arthritis Res Ther, 5
  • [32] Association between the IL-10 and IL-6 polymorphisms and brucellosis susceptibility: a meta-analysis
    Jin, Xiaochun
    Wu, Yueyuan
    Yin, Shuzhou
    Chen, Xu
    Zhang, Youtao
    [J]. BMC MEDICAL GENETICS, 2020, 21 (01)
  • [33] Association between interleukin-1 alpha rs1800587 polymorphism and rheumatoid arthritis: A meta-analysis
    Wang, Huaguo
    Wang, Yi
    [J]. SCIENCE PROGRESS, 2021, 104 (02)
  • [34] Meta-analysis of the association of CTLA-4 exon-1+49A/G polymorphism with rheumatoid arthritis
    Han, SZ
    Li, Y
    Mao, YM
    Xie, Y
    [J]. HUMAN GENETICS, 2005, 118 (01) : 123 - 132
  • [35] LACK OF ASSOCIATION BETWEEN RHEUMATOID-ARTHRITIS AND TYPE-1 (INSULIN DEPENDENT) DIABETES
    RUDGE, S
    BARON, FM
    DRURY, P
    [J]. JOURNAL OF RHEUMATOLOGY, 1982, 9 (02) : 343 - 344
  • [36] Association of interleukin-6 (IL-6)-174G/C polymorphism with cardiovascular disease in patients with rheumatoid arthritis
    Panoulas, Vasileios F.
    Smith, Jacqueline P.
    Douglas, Karen M. J.
    Stavropoulos-Kalinoglou, Antonios
    Metsios, Georgios S.
    Kitas, George D.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S271 - S271
  • [37] Association between rs1800796 polymorphism in the IL-6 gene and the risk of lung cancer: An updated meta-analysis
    Chen, Yanru
    Zhang, Na
    Wang, Xiaojun
    [J]. META GENE, 2020, 25
  • [38] Interleukin 6 (IL-6) signalling in rheumatoid arthritis
    Carty, SM
    Nowell, MA
    Goodfellow, RM
    Topley, N
    Jones, SA
    Williams, BD
    Williams, AS
    [J]. RHEUMATOLOGY, 2005, 44 : I38 - I38
  • [39] IL-6 promoter polymorphisms in rheumatoid arthritis
    M Pascual
    A Nieto
    L Matarán
    A Balsa
    D Pascual-Salcedo
    J Martín
    [J]. Genes & Immunity, 2000, 1 : 338 - 340
  • [40] IL-6 promoter polymorphisms in rheumatoid arthritis
    Pascual, M
    Nieto, A
    Matarán, L
    Balsa, A
    Pascual-Salcedo, D
    Martín, J
    [J]. GENES AND IMMUNITY, 2000, 1 (05) : 338 - 340